In-Jae Oh
0000-0003-4837-1321
8 papers found
Refreshing results…
Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population
A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer
A phase II , multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation‐positive non‐small cell lung cancer (stage III ) who have not progressed following definitive, platinum‐based, chemoradiation therapy ( PLATINUM trial)
Prognostic significance of location index in resected T1-sized early-stage non-small cell lung cancer
Clinical implication of interstitial lung abnormality in elderly patients with early‐stage non‐small cell lung cancer
Potentially fatal complications of systemic air embolism after computed tomography‐guided transthoracic needle biopsy in lung cancer harboring epithelial growth factor receptor mutation: A case report
Feasibility of re-biopsy and EGFR mutation analysis in patients with non-small cell lung cancer: Feasibility of re-biopsy in NSCLC
A Prospective Observational Study Evaluating the Correlation of <b><i>c-MET</i></b> Expression and <b><i>EGFR</i></b> Gene Mutation with Response to Erlotinib as Second-Line Treatment for Patients with Advanced/Metastatic Non-Small-Cell Lung Cancer
Missing publications? Search for publications with a matching author name.